Testicular cancer epidemiology and demographics

Jump to navigation Jump to search

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rim Halaby, M.D. [2]

Testicular cancer Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Testicular cancer from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Biopsy

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Testicular cancer epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Testicular cancer epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Testicular cancer epidemiology and demographics

CDC on Testicular cancer epidemiology and demographics

Testicular cancer epidemiology and demographics in the news

Blogs on Testicular cancer epidemiology and demographics

Directions to Hospitals Treating Testicular cancer

Risk calculators and risk factors for Testicular cancer epidemiology and demographics

Overview

Testicular cancer is most common among Caucasians and rare among African Americans. In the United States, the age-adjusted prevalence of testicular cancer is 88.1 per 100,000 in 2011.[1] Although testicular cancer is most common among men aged 15-40 years, it has three peaks: infancy, ages 25-40 years, and age 60 years.

Epidemiology and Demographics

Prevalence

  • Testicular cancer is most common among Caucasians and rare among African Americans. Testicular cancer is uncommon in Asia and Africa. Worldwide incidence has doubled since the 1960s, with the highest rates of prevalence in Scandinavia, Germany, and New Zealand.
  • In the United States, the age-adjusted prevalence of testicular cancer is 88.1 per 100,000 in 2011.[1]

Incidence

  • Incidence among African Americans doubled from 1988 to 2001 with a bias towards seminoma. The lack of significant increase in the incidence of early-stage testicular cancer during this timeframe suggests that the overall increase was not due to heightened awareness of the disease.
  • The delay-adjusted incidence of testicular cancer in 2011 was estimated to be 5.98 per 100,000 persons in the United States.[1]
  • In 2011, the age-adjusted incidence of testicular cancer was 5.88 per 100,000 persons in the United States.[1]

Age

  • Although testicular cancer is most common among men aged 15-40 years, it has three peaks: infancy, ages 25-40 years, and age 60 years.
  • Germ cell tumors of the testis are the most common cancer in young men between the ages of 15 and 35 years.
  • While the overall age-adjusted incidence of testicular cancer in the United States between 2007 and 2011 is 5.6 per 100,000, the age-adjusted incidence of testicular cancer by age category is:[1]
    • Under 65 years: 6.2 per 100,000
    • 65 and over: 1.2 per 100,000
  • Shown below is an image depicting the incidence of testicular cancer by age and race in the United States between 1975 and 2011.[1]

Incidence of testicular cancer by age and race

Race

  • Shown below is a table depicting the age-adjusted prevalence of testicular cancer by race in 2011 in the United States.[1]
All Races White Black Asian/Pacific Islander Hispanic
Age-adjusted prevalence 88.1 per 100,000 108.4 per 100,000 19.3 per 100,000 28.2 per 100,000 64.2 per 100,000
  • Shown below is an image depicting the incidence of testicular cancer by race in the United States between 1975 and 2011.[1]

Incidence of testicular cancer by race

API: Asian/Pacific Islander; AI/AN: American Indian/ Alaska Native

References

  1. 1.0 1.1 1.2 1.3 1.4 1.5 1.6 1.7 Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.


Template:WikiDoc Sources